Healthcare-focused growth fund Jashvik Capital completes first close of maiden fund

The SEBI (Securities and Exchange Board of India) registered, Category II Alternative Investment Fund (AIF), announced in July this year, expects to make its final close within a year. It will invest with a ticket size ranging from $10-50 million.

Related Keywords

India ,Naresh Patwari ,Lal Pathlabs ,Vijender Singh ,Schlumberger ,Mckinsey Company ,Exchange Board Of India ,Category Ii Alternative Investment Fund ,Ta Associates ,Jashvik Capital ,Exchange Board ,Investment Fund ,Anil Matai ,Managing Director ,Zydus Healthcare ,Chief Executive Officer ,Metropolis Healthcare ,How Dr Lal Pathlabs ,Healthcare ,Sebi ,If ,Cici ,